Scientists Discover a New DNA Formula – DRT3 and DRT7 Reveal Unusual Ways to Build DNA Without a Conventional Template

Science & Technology Report | International News Gateway

Updated: April 2026

A new wave of research into bacterial defense systems is challenging a long-standing assumption about how DNA can be synthesized. Scientists studying defense-associated reverse transcriptases (DRTs) have identified molecular systems capable of producing unusual DNA products without relying entirely on a conventional DNA or RNA template.

Two systems are particularly interesting: DRT3 and DRT7. Recent research shows that DRT3 can combine RNA-templated and protein-directed DNA synthesis, while DRT7 can use protein-mediated recognition and a linked primase-polymerase activity to generate unusual DNA structures. These findings do not mean that scientists have discovered a general-purpose method for creating arbitrary genetic codes from nothing. Instead, they reveal a previously underappreciated capability of bacterial enzymes to control DNA synthesis through protein structure and molecular interactions.

That distinction is important. The discovery is scientifically significant precisely because it expands what researchers understand about DNA polymerases while remaining grounded in experimentally observed chemistry.

What Scientists Actually Discovered About DRT3

The best-established result concerns DRT3, a bacterial anti-phage defense system studied by researchers at Stanford University and collaborators.

The DRT3 system contains two reverse transcriptase proteins, called Drt3a and Drt3b, together with a noncoding RNA component. Researchers found that the two enzymes do not perform identical jobs.

Drt3a uses a short sequence within the RNA component as a template to produce a repeating DNA strand. Drt3b behaves differently: it can synthesize a complementary DNA strand without using a conventional nucleic-acid template. Instead, features of the protein’s active site help determine which nucleotides are incorporated.

The resulting DNA contains repeating GT/AC sequences rather than a complex new genetic message.

This is why describing the discovery as a “new DNA formula” is useful as a headline, but it should not be interpreted literally as scientists discovering a universal formula for writing any desired DNA sequence.

How Protein Structure Can Influence DNA Synthesis

DNA polymerases normally use a template strand to determine which nucleotide should be added next. DRT3b provides an unusual alternative.

According to the published research, specific amino-acid residues in the enzyme’s active site act as molecular gates. Their positioning favors alternating nucleotide incorporation, allowing Drt3b to generate a repeating poly(AC) DNA product without a complementary nucleic-acid template.

In simple terms, the protein’s three-dimensional structure helps determine the chemical outcome.

That does not mean the protein contains a hidden genetic sequence in the same sense as DNA. The mechanism is much more constrained: the enzyme’s structure favors a particular repeating pattern.

Researchers therefore describe the process as protein-templated or protein-directed DNA synthesis.

DRT3 Does Not Overturn the Central Dogma

Some descriptions of this discovery have suggested that DRT3 breaks the central dogma of molecular biology. That interpretation goes too far.

The central dogma concerns the permitted directions of biological information transfer between nucleic acids and proteins. The DRT3 finding instead concerns an unusual chemical mechanism for polymerizing DNA.

The discovery is still remarkable because it demonstrates that DNA synthesis does not always require a conventional nucleic-acid template. But it does not show that proteins can freely encode complex genetic information back into DNA.

The experimentally demonstrated DRT3 product is a relatively simple repeating sequence, and researchers are still investigating its biological function.

This distinction is essential for understanding the significance of the work without overstating it.

DRT7 Reveals a Second Unusual DNA-Synthesis Mechanism

DRT7 provides another important example.

Research posted as preprints in 2026 describes DRT7 as a defense-associated reverse transcriptase containing both a reverse-transcriptase domain and a primase-polymerase domain. The system can produce protein-primed, A/T-rich DNA structures through coordinated activity between those domains.

The mechanism is different from DRT3.

In the reported DRT7 system, the reverse-transcriptase portion initiates protein-primed poly(T) synthesis. The resulting DNA can then participate in further synthesis by the primase-polymerase domain. Researchers describe the overall product as a palindromic, A/T-rich DNA structure generated through repeated molecular handoffs.

Because these findings are based in part on preprints, they should be treated as emerging research rather than settled scientific consensus.

Why DRT3 and DRT7 Matter to Molecular Biology

The importance of these systems goes beyond their unusual DNA products.

For decades, scientists have categorized polymerases according to whether they use DNA, RNA, or another molecular component to guide nucleotide incorporation. DRT systems demonstrate that this classification is more complicated than previously appreciated.

A 2026 research review describes DRTs as an emerging class of bacterial antiviral enzymes capable of producing several unconventional DNA products, including protein-templated DNA and other unusual forms of cDNA.

The broader lesson is that bacteria have evolved molecular machines that can manipulate nucleic-acid chemistry in ways that researchers are only beginning to understand.

The Connection to Bacterial Defense Against Viruses

DRT3 and DRT7 are not ordinary DNA-making enzymes that bacteria use to maintain their chromosomes.

They are associated with anti-phage defense.

Bacteriophages, commonly called phages, are viruses that infect bacteria. Bacteria have evolved numerous defense mechanisms to detect and disrupt phage infections.

In the DRT3 system, unusual DNA production appears to be part of an antiviral response. Experimental work indicates that the system can produce DNA that accumulates during defense and contributes to cellular responses against phage infection.

DRT7 research similarly links its DNA-synthesis activity to anti-phage defense and abortive infection.

The precise biological purpose of every DNA product remains an active research question.

Does This Mean Bacteria Can Create Completely New Genes?

No—not based on the evidence currently available.

This is one of the most important limitations to understand.

The DRT3 research demonstrates controlled production of repetitive DNA sequences, particularly alternating nucleotide patterns. It does not demonstrate that DRT3 can independently design and synthesize an arbitrary gene containing thousands of bases of meaningful biological information.

Likewise, current DRT7 research describes highly structured A/T-rich DNA products rather than arbitrary genetic sequences.

Future protein-engineering research could potentially explore whether related mechanisms can be redesigned for broader applications, but that possibility remains speculative.

Related Reading on International News Gateway:  Best Life Insurance Companies in the USA for Families and Seniors [2026 Guide]

Could the Discovery Lead to New DNA-Synthesis Technologies?

Possibly, but it is far too early to predict commercial applications.

Researchers are interested in unusual polymerases because new mechanisms for controlling nucleotide incorporation could eventually contribute to biotechnology.

Potential research directions include:

• studying new enzymatic DNA-synthesis mechanisms;
• developing molecular tools for studying polymerase chemistry;
• designing new classes of nucleic-acid materials;
• understanding how bacterial defense systems evolved;
• engineering enzymes with improved biochemical properties; and
• investigating whether protein-directed synthesis can be adapted for controlled laboratory applications.

However, these are research possibilities, not established medical or commercial products.

The published DRT3 work itself suggests that understanding protein-directed DNA synthesis could eventually inform synthetic biology and nucleic-acid engineering.

What This Could Teach Scientists About the Origins of Life

The findings may also contribute to fundamental questions about molecular evolution.

Scientists studying the origins of life are interested in how early chemical systems could have produced and copied nucleic acids before modern biological machinery evolved.

A protein capable of influencing DNA synthesis without a conventional nucleic-acid template provides another example of how chemical information can be constrained by molecular structure.

But it would be premature to claim that DRT3 or DRT7 explains how the first DNA-based life appeared.

These systems occur in modern organisms and are associated with sophisticated bacterial defense mechanisms. Researchers would need much more evidence before connecting them directly to early-Earth chemistry.

The discovery is therefore better viewed as a new piece of biochemical evidence that broadens the range of mechanisms scientists must consider.

What Researchers Still Do Not Know

Several important questions remain unanswered.

First, what is the exact biological purpose of the unusual DNA products?
The DRT3 system is clearly associated with bacterial defense, but the precise role of its DNA product continues to be investigated.

Second, how widespread are these mechanisms?
DRT systems appear across diverse bacterial genomes, and researchers continue to search for additional variants.

Third, how much sequence control is possible?
Current examples produce highly constrained repetitive DNA. Whether related proteins can be engineered to generate more complex sequences remains unknown.

Fourth, how did these systems evolve?
Understanding why bacteria evolved such unusual polymerases could reveal new principles of molecular evolution and antiviral defense.

DRT3 and DRT7 Are Not Yet Medical Treatments

Some headlines surrounding unconventional DNA synthesis have connected these discoveries to cancer treatment, gene therapy, vaccines, or other medical applications.

At present, those claims should be treated cautiously.

There is no evidence that DRT3 or DRT7 is currently a cancer treatment, gene-therapy platform, or approved medical technology.

The scientifically supported significance is at the level of molecular biology and biotechnology research. Any future medical application would require extensive laboratory development, safety testing, validation, and regulatory review.

Keeping that distinction clear is important for responsible science reporting.

Why the Discovery Is Still a Major Scientific Development

The excitement surrounding DRT3 and DRT7 is justified—but for a more precise reason than some viral headlines suggest.

Scientists have discovered that bacterial defense systems can use protein structure to influence DNA synthesis in ways that do not fit neatly into the conventional template-copying model.

DRT3 is particularly striking because one of its reverse transcriptase components produces a complementary DNA strand without a conventional nucleic-acid template, while the companion enzyme uses an RNA sequence to generate the other strand.

DRT7 provides a separate example in which reverse-transcriptase and primase-polymerase activities cooperate to generate unusual protein-primed DNA structures.

Together, these findings demonstrate that nature has more ways to control DNA synthesis than textbook diagrams might suggest.

Related Reading on International News Gateway: best-car-accident-lawyer-in-california

What “A New DNA Formula” Really Means

The phrase “new DNA formula” should therefore be understood as a shorthand for a newly characterized biochemical mechanism, not a mathematical formula or a method for creating arbitrary genetic information.

The key discovery is that protein structure itself can play a role normally associated with a nucleic-acid template.

That expands the known chemistry of DNA polymerases and gives researchers a new direction for studying bacterial immunity, molecular evolution, and synthetic biology.

The work also illustrates an important principle of science: surprising discoveries do not necessarily invalidate established theories. Sometimes they reveal that the underlying theory was correct but incomplete.

Final Takeaway

The emerging DRT3 and DRT7 research is one of the more intriguing developments in molecular biology in 2026.

DRT3 has been shown to combine RNA-templated and protein-directed DNA synthesis, producing highly repetitive DNA through an unusual molecular mechanism. DRT7 research points to another protein-mediated pathway involving reverse-transcriptase and primase-polymerase activities.

Neither discovery demonstrates that life can freely “write” arbitrary genetic codes or that scientists have developed a universal replacement for conventional DNA synthesis. But both findings reveal that DNA polymerization is chemically more diverse than previously recognized.

For molecular biologists, the real breakthrough is not that biology has abandoned the rules of genetics. It is that researchers have uncovered another way biological molecules can control the construction of DNA.

That makes DRT3 and DRT7 valuable subjects for continued research—and a reminder that some of the most interesting molecular machines may still be hidden inside the enormous diversity of bacteria and their evolutionary arms race with viruses.

Editorial note: This article deliberately distinguishes established findings from hypotheses and future applications. DRT3’s core findings have been reported in Science, while several DRT7 results currently remain available as 2026 preprints and therefore warrant additional independent validation.